Skin Care & Laser Physicians Looks Forward to ESKATA™
Good news for patients looking to treat their seborrheic keratoses: On Dec. 15, the U.S. FDA gave its approval to Aclaris Therapeutics’ ESKATA™. This represents the first FDA-approved topical, noninvasive treatment for a cosmetic problem that is still not fully understood by the medical community. Dermatologists are not entirely sure what causes seborrheic keratoses—sometimes …
Continue reading “Skin Care & Laser Physicians Looks Forward to ESKATA™”



